Breaking News Instant updates and real-time market news.

ELGX

Endologix

$1.68

-0.07 (-4.00%)

13:25
10/02/18
10/02
13:25
10/02/18
13:25

Endologix to host investor meeting

Investor meeting to be held in New York on October 2 at 4:15 pm. Webcast Link

  • 02

    Oct

  • 06

    Nov

  • 27

    Nov

ELGX Endologix
$1.68

-0.07 (-4.00%)

08/23/18
BTIG
08/23/18
NO CHANGE
Target $4
BTIG
Buy
Endologix price target lowered to $4 from $7 at BTIG
BTIG analyst Sean Lavin lowered his price target on Endologix to $4 to reflect the company's recent "drastic" reduction in FY18 revenue guidance, cuts in salesforce, and delayed clinical timelines. Lavin adds that Endologix's Q2 earnings call was also "completely negative", saying the stock is the "Cleveland Browns of MedTech World", with high potential but propensity for things to go wrong. The analyst keeps his Buy rating on Endologix on valuation, but adds that "investors will need the patience of a Browns' fan to stay involved."
08/10/18
PIPR
08/10/18
DOWNGRADE
Target $4.75
PIPR
Neutral
Endologix downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Matt O'Brien downgraded Endologix to Neutral and lowered his price target for the shares to $4.75 from $7. The big news from the company's Q2 results is that management is meaningfully reducing revenue guidance for the year as it moves to revamp the business, O'Brien tells investors in a research note. Changes are a good idea "but the risks here are steep (lingering employee disruption, product safety concerns) compared to the rewards ," the analyst contends. He wants to move to the sidelines and see how the reorganization of the business takes shape.
03/20/18
PIPR
03/20/18
NO CHANGE
PIPR
Endologix ENCORE study a positive sign, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien was positive on Endologix's ENCORE study results for its Ovation product, and continues to believe "additional data reads and imminent approvals in the coming years should lift shares higher." O'Brien maintained an Overweight rating on shares, recommending investors with more risk tolerance or a longer time horizon accumulate shares at this point.
01/02/18
JPMS
01/02/18
DOWNGRADE
Target $5
JPMS
Underweight
Endologix downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Michael Weinstein downgraded Endologix to Underweight and cut his price target for the shares to $5 from $6. The outlook for the company continued to "deteriorate" over the course of 2017 as pipeline and regulatory challenges mounted, Weinstein tells investors in a research note. He sees an "uncertain path to profitability" and a "very long" road to recovery for Endologix.

TODAY'S FREE FLY STORIES

UNH

UnitedHealth

$269.44

-0.82 (-0.30%)

, ANTM

Anthem

$312.20

0.5 (0.16%)

12:49
02/20/19
02/20
12:49
02/20/19
12:49
Recommendations
Magellan Health buyout 'reasonable' up to $90 per share, says SVB Leerink »

SVB Leerink analyst Ana…

UNH

UnitedHealth

$269.44

-0.82 (-0.30%)

ANTM

Anthem

$312.20

0.5 (0.16%)

CNC

Centene

$65.13

0.725 (1.13%)

MGLN

Magellan Health

$70.85

5.8 (8.92%)

WCG

WellCare

$278.49

1.42 (0.51%)

HUM

Humana

$308.33

2.98 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 07

    Mar

  • 12

    Mar

  • 19

    Mar

  • 28

    May

XEL

Xcel Energy

$53.90

0.12 (0.22%)

12:45
02/20/19
02/20
12:45
02/20/19
12:45
Hot Stocks
Xcel Energy increases dividend to 40.5c from 38c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

AMAG

Amag Pharmaceuticals

$15.83

-0.19 (-1.19%)

12:45
02/20/19
02/20
12:45
02/20/19
12:45
Conference/Events
Amag Pharmaceuticals has a conference call hosted by JPMorgan »

JPMorgan Analyst Fye will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 27

    Feb

  • 23

    Mar

INST

Instructure

$40.82

-1.75 (-4.11%)

12:44
02/20/19
02/20
12:44
02/20/19
12:44
Recommendations
Instructure analyst commentary  »

Instructure's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 03

    Mar

ACET

Aceto

$0.42

-0.625 (-59.81%)

12:41
02/20/19
02/20
12:41
02/20/19
12:41
Hot Stocks
Aceto receives Nasdaq notice due to delay in filing Form 10-Q »

Aceto Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSM

TSMC

$39.24

0.77 (2.00%)

12:40
02/20/19
02/20
12:40
02/20/19
12:40
Options
Taiwan Semi sees opening put buying »

Taiwan Semi sees opening…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMHC

Houghton Mifflin

$8.94

0.52 (6.18%)

12:37
02/20/19
02/20
12:37
02/20/19
12:37
Hot Stocks
Houghton Mifflin Harcourt launches HMH Audio in-house audio production studio »

Houghton Mifflin Harcourt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

EA

Electronic Arts

$99.25

-3.73 (-3.62%)

, ATVI

Activision Blizzard

$43.82

-0.66 (-1.48%)

12:35
02/20/19
02/20
12:35
02/20/19
12:35
On The Fly
Game On: An exclusive talk with Beamdog CEO Trent Oster »

'NEVERWINTER NIGHTS'…

EA

Electronic Arts

$99.25

-3.73 (-3.62%)

ATVI

Activision Blizzard

$43.82

-0.66 (-1.48%)

TTWO

Take-Two

$89.77

-3.52 (-3.77%)

NTDOY

Nintendo

$0.00

(0.00%)

MSFT

Microsoft

$106.99

-0.77 (-0.71%)

SNE

Sony

$46.86

0.65 (1.41%)

TCEHY

Tencent

$0.00

(0.00%)

UBSFY

Ubisoft

$0.00

(0.00%)

CCOEY

Capcom

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 03

    Mar

  • 04

    Mar

  • 04

    Mar

  • 06

    Mar

  • 07

    Mar

  • 12

    Mar

  • 13

    Mar

  • 18

    Mar

12:35
02/20/19
02/20
12:35
02/20/19
12:35
General news
FOMC minutes preview: the minutes will be scrutinized »

FOMC minutes preview: the…

OSPN

OneSpan

$20.13

3.355 (20.00%)

12:33
02/20/19
02/20
12:33
02/20/19
12:33
Downgrade
OneSpan rating change  »

Imperial downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 11

    Mar

  • 12

    Mar

  • 28

    Mar

OSPN

OneSpan

$20.21

3.435 (20.48%)

12:28
02/20/19
02/20
12:28
02/20/19
12:28
Downgrade
OneSpan rating change  »

OneSpan downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 11

    Mar

  • 12

    Mar

  • 28

    Mar

KMI

Kinder Morgan

$19.20

0.05 (0.26%)

12:27
02/20/19
02/20
12:27
02/20/19
12:27
Hot Stocks
Kinder Morgan Chairman Richard Kinder buys over 19K shares of company stock »

Kinder Morgan Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

NYT

New York Times

$32.02

0.06 (0.19%)

12:25
02/20/19
02/20
12:25
02/20/19
12:25
Hot Stocks
New York Times publisher responds to Trump's 'enemy of the people' tweet »

After President Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

RTTR

Ritter Pharmaceuticals

$0.66

-0.0104 (-1.55%)

12:25
02/20/19
02/20
12:25
02/20/19
12:25
Conference/Events
Ritter Pharmaceuticals to host conference call »

Expert call with Dr Chey,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

ZNGA

Zynga

$5.09

-0.01 (-0.20%)

12:20
02/20/19
02/20
12:20
02/20/19
12:20
Options
Defensive option play in Zynga as shares ease off 52-week highs »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 11

    Mar

  • 11

    Mar

HSY

Hershey

$109.97

0.275 (0.25%)

12:19
02/20/19
02/20
12:19
02/20/19
12:19
Earnings
Hershey issues long-term adjusted EPS growth target of 6%-8% »

Hershey in conference…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

MCS

Marcus

$40.59

1 (2.53%)

12:18
02/20/19
02/20
12:18
02/20/19
12:18
Hot Stocks
Marcus raises quarterly dividend 6.7% to 16c per share »

Directors of The Marcus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 02

    Apr

  • 02

    Apr

  • 06

    Jun

HSY

Hershey

$109.95

0.255 (0.23%)

12:18
02/20/19
02/20
12:18
02/20/19
12:18
Hot Stocks
Hershey would consider debt to EBITDA ratio over 2.0 times for acquisition »

Hershey in conference…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
02/20/19
02/20
12:17
02/20/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
02/20/19
02/20
12:16
02/20/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
02/20/19
02/20
12:15
02/20/19
12:15
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

CVS

CVS Health

$64.92

-5 (-7.15%)

, TSLA

Tesla

$302.25

-3.31 (-1.08%)

12:11
02/20/19
02/20
12:11
02/20/19
12:11
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks opened little…

CVS

CVS Health

$64.92

-5 (-7.15%)

TSLA

Tesla

$302.25

-3.31 (-1.08%)

BMY

Bristol-Myers

$51.21

-0.14 (-0.27%)

CELG

Celgene

$91.25

0.54 (0.60%)

KNDI

Kandi Technologies

$8.45

2.52 (42.50%)

GRMN

Garmin

$82.11

11.145 (15.71%)

NVTA

Invitae

$18.55

2.06 (12.49%)

OMI

Owens & Minor

$6.48

-1.46 (-18.39%)

WIX

Wix.com

$110.43

-15.275 (-12.15%)

CXO

Concho Resources

$114.44

-6.51 (-5.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 21

    Feb

  • 22

    Feb

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 27

    Feb

  • 27

    Feb

  • 28

    Feb

  • 12

    Mar

  • 18

    Mar

  • 18

    Mar

  • 19

    Mar

  • 18

    May

  • 20

    May

  • 22

    May

  • 28

    May

HSY

Hershey

$110.01

0.315 (0.29%)

12:09
02/20/19
02/20
12:09
02/20/19
12:09
Hot Stocks
Hershey reaffirms 2019 guidance at CAGNY Conference »

Hershey said that in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

KNX

Knight-Swift

$34.96

0.73 (2.13%)

12:05
02/20/19
02/20
12:05
02/20/19
12:05
Options
Knight Transportation call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

12:05
02/20/19
02/20
12:05
02/20/19
12:05
General news
U.S. corporate bond update: the calendar remains active. »

U.S. corporate bond…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.